These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26504764)

  • 41. The effects of chemical and physical penetration enhancers on the percutaneous permeation of lidocaine through equine skin.
    Stahl J; Kietzmann M
    BMC Vet Res; 2014 Jun; 10():138. PubMed ID: 24950611
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synergistic enhancement of testosterone transdermal delivery.
    Nicolazzo JA; Morgan TM; Reed BL; Finnin BC
    J Control Release; 2005 Apr; 103(3):577-85. PubMed ID: 15820405
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transdermal delivery of antiparkinsonian agent, benztropine. I. Effect of vehicles on skin permeation.
    Gorukanti SR; Li L; Kim KH
    Int J Pharm; 1999 Dec; 192(2):159-72. PubMed ID: 10567747
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tadalafil-loaded nanostructured lipid carriers using permeation enhancers.
    Baek JS; Pham CV; Myung CS; Cho CW
    Int J Pharm; 2015 Nov; 495(2):701-9. PubMed ID: 26423175
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transdermal delivery of buprenorphine through cadaver skin.
    Roy SD; Roos E; Sharma K
    J Pharm Sci; 1994 Feb; 83(2):126-30. PubMed ID: 8169777
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improvement in bioavailability of transdermally applied flurbiprofen using tulsi (Ocimum sanctum) and turpentine oil.
    Charoo NA; Shamsher AA; Kohli K; Pillai K; Rahman Z
    Colloids Surf B Biointerfaces; 2008 Sep; 65(2):300-7. PubMed ID: 18579348
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of
    Tinjacá DA; Martínez F; Almanza OA; Jouyban A; Acree WE
    ACS Omega; 2022 Oct; 7(42):37988-38002. PubMed ID: 36312332
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microemulsions as transdermal drug delivery vehicles.
    Kogan A; Garti N
    Adv Colloid Interface Sci; 2006 Nov; 123-126():369-85. PubMed ID: 16843424
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transdermal absorption of natural progesterone from alcoholic gel formulations with hydrophilic surfactant.
    Matsui R; Ueda O; Uchida S; Namiki N
    Drug Dev Ind Pharm; 2015 Jun; 41(6):1026-9. PubMed ID: 24980912
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Penetration-enhancing effect of ethanolic solution of menthol on transdermal permeation of ondansetron hydrochloride across rat epidermis.
    Krishnaiah YS; Kumar MS; Raju V; Lakshmi M; Rama B
    Drug Deliv; 2008 May; 15(4):227-34. PubMed ID: 18446568
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preparation and Evaluation of Liposomes Containing Ethanol and Propylene Glycol as Carriers for Nicotine.
    Wang H; Shao Q; Zhang Y; Ding J; Yang M; Yang L; Wang W; Cui P; Dai Z; Ma L
    Curr Drug Deliv; 2024; 21(2):249-260. PubMed ID: 37132146
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of terpene concentrations on the skin penetration of diclofenac sodium.
    Nokhodchi A; Sharabiani K; Rashidi MR; Ghafourian T
    Int J Pharm; 2007 Apr; 335(1-2):97-105. PubMed ID: 17174049
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of pH and complexation on transdermal permeation of gliquidone.
    Sridevi S; Diwan PV
    Pharmazie; 2002 Sep; 57(9):632-4. PubMed ID: 12369452
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of tocopheryl polyethylene glycol succinate on the percutaneous penetration of minoxidil from water/ethanol/polyethylene glycol 400 solutions.
    Sheu MT; Wu AB; Lin KP; Shen CH; Ho HO
    Drug Dev Ind Pharm; 2006 Jun; 32(5):595-607. PubMed ID: 16720414
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimisation of cosolvent concentration for topical drug delivery III--influence of lipophilic vehicles on ibuprofen permeation.
    Watkinson RM; Guy RH; Oliveira G; Hadgraft J; Lane ME
    Skin Pharmacol Physiol; 2011; 24(1):22-6. PubMed ID: 20616625
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of n-methyl pyrrolidone in the enhancement of aqueous phase transdermal transport.
    Lee PJ; Langer R; Shastri VP
    J Pharm Sci; 2005 Apr; 94(4):912-7. PubMed ID: 15736187
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design, synthesis of novel lipids as chemical permeation enhancers and development of nanoparticle system for transdermal drug delivery.
    Marepally S; Boakye CH; Shah PP; Etukala JR; Vemuri A; Singh M
    PLoS One; 2013; 8(12):e82581. PubMed ID: 24349315
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vehicle composition influence on the microneedle-enhanced transdermal flux of naltrexone hydrochloride.
    Milewski M; Stinchcomb AL
    Pharm Res; 2011 Jan; 28(1):124-34. PubMed ID: 20577787
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design of a transdermal formulation containing raloxifene nanoparticles for osteoporosis treatment.
    Nagai N; Ogata F; Otake H; Nakazawa Y; Kawasaki N
    Int J Nanomedicine; 2018; 13():5215-5229. PubMed ID: 30233182
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of different vehicles for laser-assisted drug permeation via skin: full-surface versus fractional ablation.
    Lee WR; Shen SC; Aljuffali IA; Li YC; Fang JY
    Pharm Res; 2014 Feb; 31(2):382-93. PubMed ID: 24022680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.